 |
Prescription and Over-the-Counter Drug Product List - 18th Edition
Cumulative Supplement Number 6: June 1998
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CAPTOPRIL; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL OXYCODONE AND ACETAMINOPHEN CAPOZIDE 25/15> ADD > AA DURAMED 325MG;5MG N40272 001 > ADD > AB BRISTOL MYERS SQUIBB 25MG;15MG N18709 001> ADD > JUN 30, 1998 > ADD > OCT 12, 1984 > DLT > AB SQUIBB 25MG;15MG N18709 001 > DLT > OCT 12, 1984 ADENOSINE CAPOZIDE 25/25 > ADD > AB + BRISTOL MYERS SQUIBB 25MG;25MG N18709 002 INJECTABLE; INJECTION > ADD > OCT 12, 1984 ADENOCARD > DLT > AB + SQUIBB 25MG;25MG N18709 002> ADD > + FUJISAWA HLTHCARE 3MG/ML N19937 002 > DLT > OCT 12, 1984> ADD > OCT 30, 1989 CAPOZIDE 50/15> DLT > + MEDCO RES 3MG/ML N19937 002 > ADD > AB + BRISTOL MYERS SQUIBB 50MG;15MG N18709 004> DLT > OCT 30, 1989 > ADD > OCT 12, 1984 ADENOSCAN > DLT > AB + SQUIBB 50MG;15MG N18709 004> ADD > + FUJISAWA HLTHCARE 3MG/ML N20059 001 > DLT > OCT 12, 1984> ADD > MAY 18, 1995 CAPOZIDE 50/25> DLT > + MEDCO RES 3MG/ML N20059 001 > ADD > AB BRISTOL MYERS SQUIBB 50MG;25MG N18709 003> DLT > MAY 18, 1995 > ADD > OCT 12, 1984 > DLT > AB SQUIBB 50MG;25MG N18709 003 > DLT > OCT 12, 1984 ALBUTEROL SULFATE CAPTOPRIL AND HYDROCHLOROTHIAZIDE > ADD > AB ZENITH GOLDLINE 25MG;15MG N75055 001 SOLUTION; INHALATION > ADD > JUN 18, 1998 ALBUTEROL SULFATE > ADD > AB 25MG;25MG N75055 002> ADD > AN BAUSCH AND LOMB EQ 0.5% BASE N75050 001 > ADD > JUN 18, 1998> ADD > JUN 18, 1998 > ADD > AB 50MG;15MG N75055 004 > ADD > JUN 18, 1998 > ADD > AB 50MG;25MG N75055 003> ADD > CANDESARTAN CILEXETIL > ADD > JUN 18, 1998> ADD > TABLET; ORAL> ADD > ATACAND CEFTIZOXIME SODIUM> ADD > ASTRA MERCK 4MG N20838 001> ADD > JUN 04, 1998 INJECTABLE; INJECTION> ADD > 8MG N20838 002 CEFIZOX> ADD > JUN 04, 1998 > DLT > + FUJISAWA EQ 500MG BASE/VIAL N50560 001> ADD > 16MG N20838 003 > DLT > SEP 15, 1983> ADD > JUN 04, 1998 > DLT > + EQ 1GM BASE/VIAL N50560 002> ADD > + 32MG N20838 004 > DLT > SEP 15, 1983> ADD > JUN 04, 1998 > DLT > + EQ 2GM BASE/VIAL N50560 003 > DLT > SEP 15, 1983 > DLT > EQ 10GM BASE/VIAL N50560 005 > DLT > MAR 19, 1993 > ADD > + FUJISAWA HLTHCARE EQ 500MG BASE/VIAL N50560 001 > ADD > SEP 15, 1983 CEFTIZOXIME SODIUM DAUNORUBICIN HYDROCHLORIDE INJECTABLE; INJECTION INJECTABLE; INJECTION CEFIZOX DAUNORUBICIN HCL PRESERVATIVE FREE> ADD > + FUJISAWA HLTHCARE EQ 1GM BASE/VIAL N50560 002 > ADD > AP GENSIA SICOR PHARMS EQ 20MG BASE/VIAL N64212 001> ADD > SEP 15, 1983 > ADD JUN 23, 1998> ADD > + EQ 2GM BASE/VIAL N50560 003> ADD > SEP 15, 1983> ADD > EQ 10GM BASE/VIAL N50560 005 DISOPYRAMIDE PHOSPHATE> ADD > MAR 19, 1993 CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER CAPSULE, EXTENDED RELEASE; ORAL> DLT > @ FUJISAWA EQ 40MG BASE/ML N50589 002 DISOPYRAMIDE PHOSPHATE> DLT > OCT 03, 1984 > DLT > @ KV PHARM EQ 100MG BASE N71929 001> ADD > @ FUJISAWA HLTHCARE EQ 40MG BASE/ML N50589 002 > DLT > AUG 19, 1988> ADD > OCT 03, 1984 CEFIZOX IN PLASTIC CONTAINER> DLT > + FUJISAWA EQ 20MG BASE/ML N50589 003 DOBUTAMINE HYDROCHLORIDE> DLT > APR 13, 1995> DLT > + EQ 40MG BASE/ML N50589 004 INJECTABLE; INJECTION> DLT > APR 13, 1995 DOBUTAMINE HCL> ADD > + FUJISAWA HLTHCARE EQ 20MG BASE/ML N50589 003 > ADD > AP LUITPOLD EQ 12.5MG BASE/ML N74545 001> ADD > APR 13, 1995 > ADD > JUN 25, 1998> ADD > + EQ 40MG BASE/ML N50589 004> ADD > APR 13, 1995 DYPHYLLINE CEPHALEXIN > DLT > INJECTABLE; INJECTION > DLT > NEOTHYLLINE CAPSULE; ORAL > DLT > + TEVA 250MG/ML N09088 001 CEPHALEXIN > ADD > @ 250MG/ML N09088 001> ADD > AB ZENITH GOLDLINE EQ 250MG BASE N61969 001> ADD > AB EQ 500MG BASE N61969 002> DLT > AB ZENITH LABS EQ 250MG BASE N61969 001 ERYTHROMYCIN ETHYLSUCCINATE> DLT > AB EQ 500MG BASE N61969 002 SUSPENSION; ORAL ERYTHROMYCIN ETHYLSUCCINATE CIMETIDINE > DLT > @ KV PHARM EQ 200MG BASE/5ML N62047 001 > DLT > @ EQ 400MG BASE/5ML N62047 002 SOLUTION; ORAL CIMETIDINE HCL> ADD > AA DURAMED 300MG/5ML N75110 001 ESTRADIOL VALERATE> ADD > JUN 18, 1998 INJECTABLE; INJECTION DELESTROGEN DAUNORUBICIN HYDROCHLORIDE > ADD > AO + BRISTOL MYERS SQUIBB 20MG/ML N09402 004 > ADD > AO + 40MG/ML N09402 003 INJECTABLE; INJECTION > ADD > + 10MG/ML N09402 002 DAUNORUBICIN HCL PRESERVATIVE FREE > DLT > AO + SQUIBB 20MG/ML N09402 004> ADD > AP + BEDFORD EQ 20MG BASE/VIAL N50731 001 > DLT > AO + 40MG/ML N09402 003> ADD > JAN 30, 1998 ESTRADIOL VALERATE HEPARIN SODIUM INJECTABLE; INJECTION INJECTABLE; INJECTION DELESTROGEN > ADD > HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%> DLT > + SQUIBB 10MG/ML N09402 002 > ADD > @ ABBOTT 5,000 UNITS/100ML N18911 007 > ADD > JAN 30, 1985 HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC> ADD > GLUCAGON HYDROCHLORIDE RECOMBINANT CONTAINER > DLT > AP ABBOTT 5,000 UNITS/100ML N19339 001> ADD > INJECTABLE; INJECTION > DLT > MAR 27, 1985> ADD > GLUCAGEN > ADD > 5,000 UNITS/100ML N19339 001> ADD > + NOVO NORDISK EQ 1MG BASE/VIAL N20918 001 > ADD > MAR 27, 1985> ADD > JUN 22, 1998 > DLT > HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% > DLT > AP ABBOTT 5,000 UNITS/100ML N18911 009 > DLT > JAN 30, 1985 GLYBURIDE > DLT > AP 10,000 UNITS/100ML N18911 008 > DLT > JAN 30, 1985 TABLET; ORAL > ADD > @ 5,000 UNITS/100ML N18911 009 GLYBURIDE (MICRONIZED) > ADD > JAN 30, 1985> ADD > AB INVAMED 1.5MG N75174 001 > ADD > @ 10,000 UNITS/100ML N18911 008> ADD > JUN 22, 1998 > ADD > JAN 30, 1985> ADD > AB 3MG N75174 002> ADD > JUN 22, 1998> ADD > AB MYLAN 1.5MG N74792 001 HYDROCHLOROTHIAZIDE; SPIRONOLACTONE> ADD > JUN 26, 1998> ADD > AB 3MG N74792 002 TABLET; ORAL> ADD > JUN 26, 1998 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE > ADD > AB GENEVA PHARMS 25MG;25MG N86881 001 SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE GRANISETRON HYDROCHLORIDE > DLT > AB GENEVA PHARMS 25MG;25MG N86881 001 TABLET; ORAL KYTRIL LIDOCAINE> ADD > @ SMITHKLINE BEECHAM EQ 2MG BASE N20305 002> ADD > JUN 15, 1998 DISC; ORAL XYLOCAINE > DLT > ASTRA 10% N14394 001 HEPARIN SODIUM > ADD > + 10% N14394 001 INJECTABLE; INJECTION> DLT > HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% LIDOCAINE HYDROCHLORIDE> DLT > AP ABBOTT 10,000 UNITS/100ML N18911 006> DLT > JAN 30, 1985 INJECTABLE; INJECTION> ADD > @ 10,000 UNITS/100ML N18911 006 LIDOCAINE HCL> ADD > JAN 30, 1985 > ADD > AP AM PHARM PARTNERS 2% N17584 001> DLT > HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% > ADD > AP 4% N17584 002> DLT > AP ABBOTT 5,000 UNITS/100ML N18911 007 > DLT > AP FUJISAWA 2% N17584 001> DLT > JAN 30, 1985 > DLT > AP 4% N17584 002 LISINOPRIL PAROMOMYCIN SULFATE TABLET; ORAL CAPSULE; ORAL ZESTRIL PAROMOMYCIN SULFATE> DLT > AB + ZENECA 2.5MG N19777 005 > ADD > AA CARACO EQ 250MG BASE N64171 001> DLT > APR 29, 1993 > ADD > JUN 30, 1997> ADD > AB 2.5MG N19777 005 > DLT > AB EQ 250MG BASE N64171 001> ADD > APR 29, 1993 > DLT > JUN 30, 1997> DLT > AB 10MG N19777 002> DLT > MAY 19, 1988> ADD > AB + 10MG N19777 002 QUINIDINE SULFATE> ADD > MAY 19, 1988 TABLET, EXTENDED RELEASE; ORAL QUINIDEX MAFENIDE ACETATE > ADD > AB + ROBINS AH 300MG N12796 002 > DLT > AB + WYETH AYERST 300MG N12796 002> ADD > POWDER FOR RECONSTITUTION; TOPICAL> ADD > SULFAMYLON> ADD > + MYLAN 5% N19832 003 RIFAMPIN> ADD > JUN 05, 1998 CAPSULE; ORAL RIFADIN NAPROXEN > ADD > AB HOECHST MARION RSSL 150MG N62303 001 RIFAMPIN TABLET, DELAYED RELEASE; ORAL > ADD > AB EON 150MG N64150 002 NAPROXEN > ADD > JAN 02, 1998> ADD > AB TEVA 375MG N75227 001> ADD > JUN 30, 1998> ADD > AB 500MG N75227 002 > ADD > RIFAPENTINE> ADD > JUN 30, 1998 > ADD > TABLET; ORAL > ADD > PRIFTIN NYSTATIN > ADD > + HOECHST MARION RSSL 150MG N21024 001 > ADD > JUN 22, 1998 SUSPENSION; ORAL NYSTATIN> ADD > AA UDL 100,000 UNITS/ML N64142 001 > ADD > RIZATRIPTAN BENZOATE> ADD > JUN 25, 1998 > ADD > TABLET; ORAL > ADD > MAXALT ORPHENADRINE CITRATE > ADD > MERCK EQ 5MG BASE N20864 001 > ADD > JUN 29, 1998 TABLET, EXTENDED RELEASE; ORAL > ADD > + EQ 10MG BASE N20864 002 NORFLEX > ADD > JUN 29, 1998> ADD > AB + 3M 100MG N12157 001> ADD > ORPHENADRINE CITRATE > ADD > TABLET, ORALLY DISINTEGRATING; ORAL> ADD > AB INVAMED 100MG N40284 001 > ADD > MAXALT-MLT> ADD > JUN 19, 1998 > ADD > MERCK EQ 5MG BASE N20865 001 > ADD > JUN 29, 1998 > ADD > RIZATRIPTAN BENZOATE TACROLIMUS> ADD > TABLET, ORALLY DISINTEGRATING; ORAL INJECTABLE; INJECTION> ADD > MAXALT-MLT PROGRAF> ADD > + MERCK EQ 10MG BASE N20865 002 > ADD > + FUJISAWA HLTHCARE EQ 5MG BASE/ML N50709 001> ADD > JUN 29, 1998 > ADD > APR 08, 1994 STREPTOMYCIN SULFATE TETRACYCLINE HYDROCHLORIDE INJECTABLE; INJECTION CAPSULE; ORAL STREPTOMYCIN SULFATE ACHROMYCIN V> ADD > AP + PFIZER EQ 1GM BASE/VIAL N60076 001 > ADD > AB ESI LEDERLE 250MG N50278 003> ADD > AP PHARMA TEK EQ 1GM BASE/VIAL N64210 001 > ADD > AB + 500MG N50278 001> ADD > JUN 30, 1998 > DLT > AB LEDERLE 250MG N50278 003 > DLT > AB + 500MG N50278 001 SUCRALFATE TRETINOIN TABLET; ORAL SUCRALFATE SOLUTION; TOPICAL> ADD > AB RATIOPHARM 1GM N74415 001 RETIN-A> ADD > JUN 08, 1998 > DLT > + J AND J 0.05% N16921 001 > ADD > AT + JOHNSON AND JOHNSON 0.05% N16921 001 > ADD > TRETINOIN SULFACETAMIDE SODIUM > ADD > AT COPLEY PHARM 0.05% N74873 001 > ADD > JUN 19, 1998 SOLUTION/DROPS; OPHTHALMIC> DLT > SULF-10> DLT > AT CIBA 10% N80025 001 TRIMETHAPHAN CAMSYLATE> ADD > @ 10% N80025 001 > DLT > INJECTABLE; INJECTION > DLT > ARFONAD TACROLIMUS > DLT > + ROCHE 50MG/ML N08983 001 > ADD > @ 50MG/ML N08983 001 CAPSULE; ORAL PROGRAF> DLT > + FUJISAWA EQ 1MG BASE N50708 001> DLT > APR 08, 1994> DLT > + EQ 5MG BASE N50708 002> DLT > APR 08, 1994> ADD > + FUJISAWA HLTHCARE EQ 1MG BASE N50708 001> ADD > APR 08, 1994> ADD > + EQ 5MG BASE N50708 002> ADD > APR 08, 1994 INJECTABLE; INJECTION PROGRAF> DLT > + FUJISAWA EQ 5MG BASE/ML N50709 001> DLT > APR 08, 1994
CIMETIDINE TABLET; ORAL> ADD > CIMETIDINE> ADD > LEK PHARM 100MG N75122 001> ADD > JUN 19, 1998> ADD > 200MG N75122 002> ADD > JUN 19, 1998> ADD > NOVOPHARM 200MG N74961 001> ADD > JUN 19, 1998> ADD > PERRIGO 100MG N74972 001> ADD > JUN 19, 1998> ADD > PHARM FORM 200MG N74963 001> ADD > JUN 19, 1998> ADD > TORPHARM 100MG N74948 001> ADD > JUN 19, 1998 Last update: July 15, 2005 | |
